Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Recurrence × azaspirane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Dexamethasone 21 Cyclophosphamide 21 Rituximab 16 Cytarabine 16 Methotrexate 11 Gemcitabine 11 fludarabine 10 Filgrastim 10 Bortezomib 10 Lenalidomide 9 Paclitaxel 8 Etoposide 8 pembrolizumab 7 Vincristine 7 Cyclosporine 7 Antilymphocyte Serum 7 pomalidomide 6 fludarabine phosphate 6 carfilzomib 6 Topotecan 6 Temozolomide 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Docetaxel 6 Calcium Dobesilate 6 venetoclax 5 Pemetrexed 5 Mycophenolic Acid 5 Mitoxantrone 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00430014 2012-02-15

Study of Atiprimod Treatment for Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Terminated

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡